HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jian Ma Selected Research

Equine Infectious Anemia (Swamp Fever)

1/2018Characterization of Equine Infectious Anemia Virus Long Terminal Repeat Quasispecies In Vitro and In Vivo.
11/2011An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern.
9/2011The pathogenic and vaccine strains of equine infectious anemia virus differentially induce cytokine and chemokine expression and apoptosis in macrophages.
2/2011Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jian Ma Research Topics

Disease

124Neoplasms (Cancer)
05/2022 - 07/2003
29Neoplasm Metastasis (Metastasis)
01/2022 - 09/2005
28Carcinogenesis
06/2022 - 05/2006
26Inflammation (Inflammations)
10/2022 - 01/2011
23Nasopharyngeal Carcinoma
12/2020 - 12/2002
22Infections
07/2022 - 01/2007
17Breast Neoplasms (Breast Cancer)
03/2022 - 07/2011
15Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 07/2011
14Tachycardia (Tachyarrhythmias)
12/2019 - 10/2003
10Endometrial Neoplasms (Endometrial Cancer)
06/2022 - 02/2018
10Stomach Neoplasms (Stomach Cancer)
04/2022 - 12/2012
10Prostatic Neoplasms (Prostate Cancer)
10/2021 - 01/2009
9Atherosclerosis
01/2021 - 01/2007
8Atrial Fibrillation
01/2022 - 12/2006
8Wounds and Injuries (Trauma)
07/2021 - 06/2013
7Fibrosis (Cirrhosis)
08/2022 - 04/2006
7Leukemia
01/2022 - 01/2009
7Epstein-Barr Virus Infections
01/2021 - 05/2006
7Hepatocellular Carcinoma (Hepatoma)
08/2020 - 02/2014
7Lymphatic Metastasis
12/2019 - 06/2005
6Obesity
10/2022 - 11/2015
6Colitis
01/2022 - 07/2013
6Type 2 Diabetes Mellitus (MODY)
01/2022 - 11/2015
6Glioma (Gliomas)
01/2021 - 01/2011
6Hypoxia (Hypoxemia)
01/2020 - 06/2014
6Colonic Neoplasms (Colon Cancer)
12/2019 - 11/2008
6Ventricular Tachycardia
06/2017 - 02/2004
5COVID-19
07/2022 - 03/2020
5Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2022 - 11/2011
5Pain (Aches)
02/2021 - 06/2016
5Carcinoma (Carcinomatosis)
01/2021 - 06/2005
5Myocardial Infarction
10/2020 - 08/2012
4Colitis-Associated Neoplasms
06/2022 - 01/2014
4Infarction (Infarctions)
04/2022 - 01/2011
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 03/2014
4Adenocarcinoma of Lung
11/2021 - 01/2017
4Cicatrix (Scar)
09/2021 - 01/2015
4Glaucoma
09/2021 - 05/2011
4Vesicular Stomatitis
02/2021 - 12/2017
4Heart Failure
01/2021 - 05/2009
4Equine Infectious Anemia (Swamp Fever)
01/2018 - 02/2011
4Lymphoma (Lymphomas)
08/2015 - 09/2002
3Ulcerative Colitis
01/2022 - 10/2013
3Pneumonia (Pneumonitis)
01/2022 - 11/2015
3Dyslipidemias (Dyslipidemia)
01/2022 - 01/2017
3Urinary Bladder Neoplasms (Bladder Cancer)
09/2021 - 12/2019
3Ovarian Neoplasms (Ovarian Cancer)
09/2021 - 01/2014
3Reperfusion Injury
02/2021 - 12/2010

Drug/Important Bio-Agent (IBA)

54Proteins (Proteins, Gene)FDA Link
10/2022 - 05/2006
29MicroRNAs (MicroRNA)IBA
08/2022 - 04/2010
26CytokinesIBA
08/2022 - 08/2005
20Biomarkers (Surrogate Marker)IBA
01/2022 - 04/2012
19Long Noncoding RNAIBA
08/2022 - 01/2016
19Messenger RNA (mRNA)IBA
01/2022 - 12/2008
14Pharmaceutical PreparationsIBA
04/2022 - 01/2012
11RNA (Ribonucleic Acid)IBA
06/2022 - 05/2006
11DNA (Deoxyribonucleic Acid)IBA
01/2021 - 12/2008
10VaccinesIBA
07/2022 - 02/2011
10Circular RNAIBA
03/2022 - 01/2017
9Phosphotransferases (Kinase)IBA
01/2022 - 01/2013
9LipidsIBA
01/2022 - 01/2007
8Glucose (Dextrose)FDA LinkGeneric
08/2022 - 11/2015
8LactoferrinIBA
06/2022 - 01/2012
8Therapeutic UsesIBA
01/2022 - 07/2002
8Biological ProductsIBA
01/2021 - 07/2012
8Interleukin-6 (Interleukin 6)IBA
01/2019 - 01/2011
7CateninsIBA
08/2022 - 07/2012
6Neutralizing AntibodiesIBA
11/2021 - 08/2011
6Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 06/2013
5Small Interfering RNA (siRNA)IBA
08/2022 - 12/2008
5AzoxymethaneIBA
06/2022 - 07/2013
5Peptides (Polypeptides)IBA
09/2021 - 06/2009
5UbiquitinIBA
01/2020 - 01/2015
5Transcription Factors (Transcription Factor)IBA
01/2020 - 09/2017
4CollagenIBA
08/2022 - 12/2003
4Dextran SulfateIBA
06/2022 - 10/2013
4Matrix Metalloproteinases (MMPs)IBA
01/2022 - 03/2015
4Cisplatin (Platino)FDA LinkGeneric
11/2021 - 02/2011
4Glycoproteins (Glycoprotein)IBA
02/2021 - 01/2012
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 07/2013
4oxidized low density lipoproteinIBA
10/2020 - 04/2012
4Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2020 - 07/2011
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 01/2013
4Interleukin-17 (Interleukin 17)IBA
01/2018 - 01/2011
4Interleukin-10 (Interleukin 10)IBA
12/2017 - 12/2008
4Cadherins (E-Cadherin)IBA
12/2017 - 01/2012
4CalpainIBA
06/2013 - 12/2010
3Fibronectins (Fibronectin)IBA
08/2022 - 05/2002
3Caspase 3 (Caspase-3)IBA
08/2022 - 08/2015
3Retinaldehyde (Retinal)IBA
01/2022 - 01/2016
3AntigensIBA
01/2022 - 01/2014
3Antiviral Agents (Antivirals)IBA
01/2021 - 12/2017

Therapy/Procedure

46Therapeutics
01/2022 - 09/2002
19Catheter Ablation
01/2022 - 10/2003
13Drug Therapy (Chemotherapy)
10/2021 - 09/2002
7Immunotherapy
01/2022 - 11/2018
6Radiofrequency Ablation
01/2022 - 02/2012
5Injections
08/2021 - 08/2015
3Aftercare (After-Treatment)
10/2022 - 01/2020
3Cardiopulmonary Bypass (Heart-Lung Bypass)
05/2021 - 01/2009